Overview

Generic Injectables Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Generic injectables are drugs equivalent to their branded counterparts that do not require any drug patents. These drugs are effective and safe like their innovator drugs as they have similar dosage, active ingredients, quality, strength, form, etc. the research and development cycle of these injectables is shorter and cheaper even though manufacturing them is a complicated process. Furthermore, generic drugs do not require hefty investments as compared to branded drugs who need investments in marketing and research and development. Additionally, there is no stern competition in the generic injectable sector when compared to oral generics. Moreover, many governments are supporting to manufacture generic injectables owing to their various advantages. With rising drug shortages in countries like the United States coupled with several branded drugs facing patent expirations shall bolster the market growth.

Generic Injectables Market

Market Segmentation:

By Container Type
•    Vials
•    Premix
•    Prefilled Syringes
•    Ampoules 
•    Others    
By Application
•    Oncology
•    Infectious Diseases
•    Cardiology
•    Diabetes
•    Immunology
•    Others
By Route of Administration
•    Intravenous
•    Intramuscular 
•    Subcutaneous
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into container type, application, route of administration and region. The container type segment is fragmented into vials, premix, prefilled syringes, ampoules and others. The application segment is classified into oncology, infectious diseases, cardiology, diabetes, immunology and others. The route of administration segment is diversified into intravenous, intramuscular, subcutaneous and others.  

Regional Analysis:

The Asia Pacific region is anticipated to lead the market during the forecast period owing to the increased demand of these injectables with the rising incidences of infectious diseases like typhoid, diarrhoea, cholera, malaria and cancers, high insistence for cheaper medical alternatives and a strong presence of key market players in the region. The North America region, on the other hand, is anticipated to proliferate the market during the forecasted timeframe owing to the approval of novel generic injectables and increasing insistence for cheaper biosimilar products along with increased occurrence of lifestyle-oriented diseases.

Competitive Landscape:                            

Some of the key market players associated are Pfizer, Inc., Novartis AG (Sandoz International GmbH), Baxter, Fresenius SE & Co., Mylan N.V., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC., Lupin Ltd., Sanofi, Biocon.
Pfizer Inc. dominates the global market with over one tenth of the overall market share. Currently, the company is preparing the procedure of developing a formula PF-06881894 which is a biosimilar to Neulasta and which can be used by oncology practitioners. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global generic injectables market by container type, by application, by route of administration and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions            

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics